July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Increased infiltration of immune cell subsets and altered soluble factor profile in aqueous humor of glaucoma patients correlates with disease severity
Author Affiliations & Notes
  • Archana Padmanabhan Nair
    GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India
    Manipal Academy of Higher Education, Manipal, Karnataka, India
  • Ganesh Ram Sahu
    GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India
  • Sushma Tejwani
    Glaucoma Services, Narayana Nethralaya, Bengaluru, Karnataka, India
  • Arkasubhra Ghosh
    GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India
  • Swaminathan Sethu
    GROW Research Laboratory, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India
  • Footnotes
    Commercial Relationships   Archana Nair, None; Ganesh Sahu, None; Sushma Tejwani, None; Arkasubhra Ghosh, None; Swaminathan Sethu, None
  • Footnotes
    Support  Narayana Nethralaya Foundation
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 674. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Archana Padmanabhan Nair, Ganesh Ram Sahu, Sushma Tejwani, Arkasubhra Ghosh, Swaminathan Sethu; Increased infiltration of immune cell subsets and altered soluble factor profile in aqueous humor of glaucoma patients correlates with disease severity. Invest. Ophthalmol. Vis. Sci. 2019;60(9):674.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Glaucomatous optic neuropathy results in progressive irreversible vision loss. The role of immune imbalance in mediating optic nerve degeneration is less understood. We investigated the types of infiltrating immune cells and soluble factors in aqueous humour (AH) and their relationship with disease severity in patients with primary glaucoma (GL).

Methods : AH was collected from GL and cataract (control) patients during surgical intervention without deviating from standard of care, following written, informed consent and prior approval by the institutional ethics committee. GL patients were grouped based on disease severity (Visual Field Index score and vertical cup to disc ratio - vCDR). Cells from AH (ctrl n=9, GL n=15) were phenotyped using fluorochrome conjugated antibodies specific for leukocytes (CD45), T cells (CD3), B cells (CD19), neutrophils (CD66b), monocytes (CD14), Natural Killer cells (NK; CD56) and NKT cells (CD3+ CD56+) by flow cytometry. Soluble factors in AH (ctrl n=20, GL n=55; non-severe n=25, severe n=30) were measured by multiplex ELISA.

Results : Significantly (*P<0.05) higher proportions of *CD19+, *CD56+ and CD3+ cells were observed in AH of patients with severe forms of GL compared to non-severe forms and controls. CD19+ cells were inversely related to VFI score (*r = -0.668) and positively related with vCDR (*r = 0.655). Similarly, CD56+ cells correlated negatively with VFI score (*r = -0.679) and positively with vCDR (*r = 0.756). CD19+ cell numbers showed association with AH sFasL (*r = -0.523) and Eotaxin (*r = 0.563) levels. CD56+ cell numbers showed association with AH sICAM1 (*r = 0.587) and sFasL (*r = -0.598) levels. *sFasL, *IP-10 and *bFGF were lower in AH of severe patients compared to non-severe. Factors associated with neurodegeneration such as *NGAL, *Eotaxin, *MMP2, *IL-8, *sICAM1, *Perforins and *Granzymes were high in GL AH.

Conclusions : Increased B and NK cells infiltration, along with decreased neuroprotective factors in AH are associated with severe forms of GL may suggest their pathogenic role in optic nerve degeneration. The observed increase in soluble immune factors with ability to facilitate neurodegeneration may have a causal relationship with disease severity. Hence, targeted immunomodulation might be beneficial in the management of glaucoma.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×